ADDF-Harrington Scholar Award
This programme provides dedicated support from a project management team and pharmaceutical industry experts, as well as funding of up to $600,000. The call for letters of intent opened 1 June 2022. Learn more.
Harrington UK Rare Disease Scholar Award
This programme provides UK researchers with a unique opportunity for funding and personalised discovery and development support. The call for letters of intent opened 13 June 2022. Learn more.
Watch the most recent Oxford-Harrington Rare Disease Centre webinar, Accelerating Cures in Rare Disase, to learn how the OHC brings together the strengths and capabilities of the University of Oxford in the UK and the Harrington Discovery Institute in Cleveland, Ohio, US.
The Oxford-Harrington Rare Disease Centre (OHC), a partnership of the University of Oxford and Harrington Discovery Institute at University Hospitals in Cleveland, Ohio, today announced its support of a novel treatment for Duchenne muscular dystrophy, a rare neuromuscular disease characterized by progressive muscle degeneration and weakness. The research project is led by Angela Russell, DPhil, who is Professor of Medicinal Chemistry at the University of Oxford and a 2021 Harrington UK Rare Disease Scholar. Learn more.
Advance towards the clinic
Philanthropic funding with no strings
To create next generation medicines
We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience. It is mandatory to procure user consent prior to running these cookies on your website.